Related Experiment Video
Updated: Jul 9, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
The association between the IFIH1 locus and type 1 diabetes
1Endocrine Genetics Lab, The McGill University Health Center (Montreal Children's Hospital), 2300 Tupper, Montreal, QC, Canada, H3H 1P3.
Diabetologia
|December 12, 2007
Summary
This study validated a genetic link between IFIH1 gene variations and type 1 diabetes in a European cohort. The findings confirm IFIH1 as a key gene associated with type 1 diabetes risk.
Area of Science:
- Genetics
- Immunology
- Endocrinology
Background:
- Type 1 diabetes (T1D) is an autoimmune disease with a significant genetic component.
- Previous studies suggested a T1D association with variations in the Interferon-Induced Helicase 1 (IFIH1) gene.
- Validation in independent populations is crucial for confirming genetic associations.
Purpose of the Study:
- To independently validate the previously reported association between IFIH1 gene variations and type 1 diabetes.
- To investigate this association in a new cohort of mixed European descent.
Main Methods:
- Genotyping of five single-nucleotide polymorphisms (SNPs) within the IFIH1 locus.
- Study population comprised 589 type 1 diabetes nuclear family trios (1,767 individuals).
- A family-based association analysis approach was employed.
Main Results:
- The study successfully replicated the previously reported genetic association between IFIH1 variations and type 1 diabetes.
- The association was confirmed using a robust family-based approach.
Conclusions:
- The IFIH1 gene region, including candidate genes FAP, IFIH1, and GCA, is associated with type 1 diabetes.
- Further research involving variant discovery and fine mapping is needed to elucidate the precise mechanism of T1D development.
- This highlights a potential novel pathway in type 1 diabetes pathogenesis.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...